4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-024661
VP Clinical Reg Affairs bought 250 shares at $9.49 ($2,373)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Jaye VP Clinical Reg Affairs | 2023-07-13 | Purchase | +250 | $9.49 | $2,373 | 259,248 | D |
| Open-market purchases · 250 sh · avg $9.49 · $2,373 | |||||||
Loading xslF345X05/ownership.xml…